Workplace Flu Vaccinations
Workplace Flu Vaccinations for 2025
Workplace flu vaccinations are a great way to protect your employees. Together with our partner, Healthworks, we offer onsite flu vaccinations for businesses across Australia and can create a tailored solution to prepare your business for a healthy year.
Influenza in 2025
Influenza, also known as the “flu”, can have a powerful effect on an organisation and their workers’ health due to causing high rates of absenteeism and lower rates of productivity annually. That is why it is important to start planning early, so that you can protect your workplace from the flu.
Together with health and wellbeing division of our business, Healthworks, we can create a tailored solution to prepare your business for the 2025 flu season and ensure that your employees are fit and healthy all year round.
The effect of the flu on your business
Each year, the flu costs Australian businesses more than $2 billion, with an estimated 1,500,000 workdays lost each year due to the illness. Unlike a cold, the flu can last for a week or more, and individuals can feel fatigue for a period of two to three weeks.
The influenza virus is also highly contagious, with the infection transferring from person to person before noticeable symptoms are present. Therefore, prevention through an annual onsite vaccination program can be the key to keeping your workforce healthy.
Corporate flu vaccinations
When you implement your workplace flu vaccination program, a specialist immunisation nurse will attend your workplace to provide the influenza vaccine to workers onsite. A corporate flu vaccination program is one of the easiest programs to incorporate into your business. It only takes a few minutes out of an employees’ workday, and, in return, the business reaps long term positive effects associated with employee health costs.
Our sister division, Healthworks, partners with Australia Vaccine Services (AVS) to provide you with highly experienced end-to-end project management, along with fully qualified and insured immunisation nurses who have completed over 395,000 vaccinations in the past 6 years. Our team is able to work with the unique needs of your business to provide a fully customisable service nationally.
Once booked, our specialised immunisation team will administer the 2025 flu vaccines to your employees in a professional and efficient manner. We also provide offsite flu shots for staff who are unable to attend on the scheduled day(s) of your vaccination program.
The benefit of workplace flu shots
Influenza vaccination can prevent illness in about 50–60% of young children and healthy adults under the age of 65 years, although this figure varies year-to-year.
The flu vaccine and workplace flu vaccinations can also help prevent injuries, as employees who continue to complete their regular tasks when they have the flu are at a higher risk of injury due to 20-40% slower reaction times.
Apart from becoming ill, having influenza can be a big inconvenience. People can miss time from work because they are either too sick to attend, or they have to take time off to care for a sick child. One study has even shown that parents of children under 3 years of age missed an average of 3 days of work to stay home and care for their sick child.
Do you still have questions about the flu vaccination?
Check out our “Frequently Asked Questions about Flu Shots” page to learn more about the flu vaccines administered and the service that we can provide for your business.
How effective is the flu vaccine?
Clinical trial results have found that the influenza vaccine can be 70% more effective in protecting against the severe effects of infection in healthy adults.
The Australian flu vaccine 2024
Each year, the World Health Organization (WHO) puts forward its recommendations for the composition of that year’s influenza virus vaccines.
In 2024, the Australian Influenza Vaccine Committee (AIVC) recommended the following viruses for the 2024 southern hemisphere season quadrivalent influenza vaccines:
The WHO recommends that trivalent vaccines for use in the 2024 southern hemisphere influenza season contain the following:
-
- an A/Victoria/4897/2022 (H1N1)pdm09-like virus;
- an A/Thailand/8/2022 (H3N2)-like virus; and
- a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.
-
- an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
- an A/Massachusetts/18/2022 (H3N2)-like virus; and
- a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.
-
For quadrivalent egg- or cell culture-based or recombinant vaccines for use in 2024 southern hemisphere influenza season, the WHO recommends inclusion of the following B/Yamagata lineage component:
- a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.